AB
SCPH

Amalgamated Bank’s scPharmaceuticals SCPH Stock Holding History

Amalgamated Bank’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,358
Closed -$8K – 2998
2025
Q3 		$8K Hold
1,358
– – ﹤0.01% 2575
2025
Q2 		$5K Hold
1,358
– – ﹤0.01% 2784
2025
Q1 		$4K Buy
1,358
+385
+40% +$1.25K ﹤0.01% 2745
2024
Q4 		$3K Hold
973
– – ﹤0.01% 2871
2024
Q3 		$4K Hold
973
– – ﹤0.01% 2846
2024
Q2 		$4K Hold
973
– – ﹤0.01% 2880
2024
Q1 		$5K Sell
973
-3,114
-76% -$17.4K ﹤0.01% 2736
2023
Q4 		$26K Sell
4,087
-290
-7% -$1.66K ﹤0.01% 2539
2023
Q3 		$31K Hold
4,377
– – ﹤0.01% 2463
2023
Q2 		$45K Buy
+4,377
New +$45.7K ﹤0.01% 2368

Amalgamated Bank's SCPH Position: Q4 2025 in Review

Amalgamated Bank sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 1,358 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in SCPH in Q2 2023 and held it in 10 quarters. The position peaked at $45K in Q2 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Amalgamated Bank reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,358 scPharmaceuticals shares in Q4 2025, an estimated $8K.
  • Amalgamated Bank first reported a position in scPharmaceuticals in Q2 2023 and held it in 10 quarters.
  • Amalgamated Bank's scPharmaceuticals position peaked at $45K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Amalgamated Bank's 13F filing for Q4 2025, filed 5 Feb 2026.